XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating Activities    
Net earnings $ 497,277 $ 301,045
Adjustments to reconcile net earnings to cash from operating activities:    
Depreciation and amortization 145,325 136,355
Share-based compensation expense 18,393 8,220
Gain on sale of businesses 0 5,770
Other, net (9,493) (9,021)
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):    
Accounts receivable, net (192,192) 73,317
Inventories (144,903) (80,883)
Prepaid expenses and other assets (23,133) (12,975)
Accounts payable 149,588 (93,609)
Accrued compensation and employee benefits (13,566) (63,621)
Accrued expenses and other liabilities 14,289 77,336
Accrued and deferred taxes, net (4,328) 17,278
Net cash provided by operating activities 437,257 347,672
Investing Activities    
Additions to property, plant and equipment (73,231) (79,171)
Acquisitions, net of cash acquired (81,187) (238,839)
Proceeds from sale of property, plant, and equipment 6,088 2,886
Proceeds from sale of businesses 0 16,850
Other (2,873) 0
Net Cash Provided by (Used in) Investing Activities (151,203) (298,274)
Financing Activities    
Repurchase of common stock, including prepayment under an accelerated share repurchase program (21,637) (52,916)
Change in commercial paper and notes payable 0 420,300
Dividends paid to stockholders (142,698) (141,570)
Payments to settle employee tax obligations on exercise of share-based awards (33,068) (11,217)
Other (2,785) (1,101)
Net cash used in by financing activities (200,188) 213,496
Effect of Exchange Rate on Cash and Cash Equivalents 2,418 (11,115)
Net (decrease) increase in cash and cash equivalents 88,284 251,779
Cash and cash equivalents at beginning of period 513,075 397,253
Cash and cash equivalents at end of period $ 601,359 $ 649,032